Recombinant Human HMGB1 Protein，His

High-mobility group box 1 (HMGB1) is a highly conserved nuclear protein that plays a crucial role in cellular processes such as DNA repair, gene expression, and chromatin remodeling. It is also recognized as an important extracellular signaling molecule involved in inflammation and immune responses. Research has indicated that HMGB1 can act as a pro-inflammatory cytokine when released from damaged or infected cells, contributing to various pathological conditions including autoimmune diseases, sepsis, and cancer. Due to its significant role in these processes, HMGB1 has emerged as a potential therapeutic target. The production of recombinant HMGB1 protein allows for detailed studies of its biological functions, mechanisms of action, and interactions with other proteins and receptors. These studies are essential for understanding its dual roles in the nucleus and extracellular environment, as well as for developing HMGB1-based biomarkers and therapeutic interventions. The investigation of HMGB1 at the protein level enables researchers to explore its post-translational modifications, binding properties, and effects on cellular signaling pathways, thus providing insights into its involvement in various diseases and the potential for novel treatment strategies. Overall, the study of recombinant HMGB1 protein holds promise for elucidating its multifaceted role in health and disease, paving the way for future clinical applications and the development of HMGB1-targeted therapies.